web analytics
History of drug development experience from top pharmaceutical companies | Velesco Pharma

Our History

Velesco Pharmaceutical Services brings the benefits of understanding the challenges faced during the drug development process.

 

Velesco was formed in 2007 by former Pfizer Michigan Research & Development (Pharmaceutical Science) colleagues. Velesco’s founders are analytical chemists with drug formulation and manufacturing experience, and decades of experience in both early phase and later phase drug development.  This team of pharmaceutical industry veterans was trained at various top pharmaceutical companies with research and development facilities that were located in Michigan, including such legacy companies as Pfizer, Warner Lambert, Parke Davis, Upjohn and Pharmacia, among others.

 

Velesco operates from state-of-the-art facilities and has maintained a focus on providing early phase drug formulation, analytical method development and cGMP clinical supply materials to small to mid-sized biotech and pharmaceutical companies. We have an experienced team who has worked on over 200 drug development programs and is eager to assist our clients, both returning and new!

 

Velesco Pharmaceutical Services' Team

News and Events

Pace® Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services

Read the Press Release!


Dave Barnes, Ph.D. CEO/CSO is a featured speaker for the webinar Topical Formulation: Selection of Excipients and Better Process Understanding for Success in Commercial Manufacturing. Webinar recording available now.

View Recording!


Newly Acquired DEA Analytical Laboratory License. We are licensed to use schedules 2, 2N, 3, 3N, 4, and 5.


In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services.


Roundtable: M&A trends in CDMO - Molecule to Market


New Velesco Pharma clinical manufacturing facility begins operations.

Read the press release here.


Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.

Read the interview here.


Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group.

Read the press release here.


CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!


1 new job postings! Careers


Velesco's work published

Formulation Development & Manufacturing:
Using a Single Provider Reduces Costs & Risk
Read it here.


Follow Velesco

LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter FB FindUsOnFacebook 100

734-274-9877